Prevalence of Expanded Dengue Syndrome in Patients with Dengue Virus Infection at the Dr. Soetomo Hospital Surabaya in 2017 – 2018

Avina Fimas Adissadah, Aryati Aryati, Suhintam Pusarawati


Dengue Fever (DF) or Dengue Hemorrhagic Fever (DHF) is one of the infectious diseases that attracts much global attention, especially Indonesia because it impacts the mortality rate of the people in the world if adequate treatment is not given. Expanded Dengue Syndrome (EDS) is a clinical manifestation involving several organs such as lungs, liver, kidney, heart, and brain-related to dengue infections, with or without plasma leakage. This study aimed to determine the prevalence of expanded dengue syndrome in patients with dengue virus infection at the Dr. Soetomo Hospital in 2017–2018. Based on its purpose, the sampling technique used in this study was the total sampling of patients with DVI who admitted to Dr. Soetomo Hospital Surabaya. Every pediatric and adult patient who met the criteria were included in this study until a certain period in 2017–2018.  After the data collection, only thirty samples of EDS from the 196 sample data were collected. Thirty patients with expanded dengue syndrome had a manifestation of different organs. Such as: neurological, cardiac, respiratory system, gastro-hepatic, and kidneys. The laboratory test results showed that most platelet counts of 51,000 – 100,000 were found in seventeen patients, while the range of hemoglobin and hematocrit was normal. From a total of thirty samples of dengue virus infection patients with EDS, there were only eighteen patients who did a serological test. The most found serological results were (+/-) anti-dengue IgM and (+) anti-dengue IgG (40%).


Dengue, dengue hemorrhagic fever, tropical disease

Full Text:



World Health Oganization. Dengue guidelines for diagnosis, treatment, prevention and control. 2011 [cited at June 28, 2018]. Available at: http://

Kementrian Kesehatan Republik Indonesia. Profil Kesehatan Provinsi Jawa Timur tahun 2017 – 2018. [cited at January 21, 2019]. Available at: http://

Sri Rezeki, Sugeng Sugijanto, Suharyono Wurhadi, Thomas Suroso. 2014. Tata Laksana Demam Dengue/Demam Berdarah Dengue. Dirjen P2M & PLP, Depkes RI.

Karyanti MR, Hadinegoto SR. The changing incidence of dengue haemorrhagic fever in Indonesia. BMC infect Dis 14, 412 (2014). Doi:10.1186/1471-2334-14-412

Gulati S, Maheshwari A. Atypical Manifestation in Dengue. Trop Med Int Health. 2007 Sep; 12(9):1087-95.

Kaushik JS, Gupta P, Rajpal S, Bhatt S. Spontaneous resolution of sinoatrial exit block and atrioventricular dissociation in a child with dengue fever. Singapore Med J. 2010 Sep; 51(9):e146-8.

Wiersinga WJ, Scheepstra CG, Kasanardjo JS, de Vries PJ, Zaaijer H, Geerlings SE. Dengue fever–induced hemolytic uremic syndrome. Clin Infect Dis. 2006;43:800–1.

Nair VR, Unnikrishnan D. Acute Renal Failure in Dengue Fever in the Absence of Bleeding Manifestations or Shock. lnfect Dis Clin Pract. 2005;13(3):142–3.

Sastri N, Lestari A. Gambaran Hasil Pemeriksaan Darah Lengkap pada Pasien Suspect IVD. E-jurnal Medika. 2016.5(7): 2303-1395

David A. Muller, Alexandra C. I. Depelsenaire, Paul R. Young, Clinical and Laboratory Diagnosis of Dengue Virus Infection, The Journal of Infectious Diseases. 2017;215:89–95.



  • There are currently no refbacks.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.